5 terminated. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Terminated 5 |
Follow Hyperlipidemia: new trials by email Literature Review of Hyperlipidemia trials Research Report on Hyperlipidemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Evacetrapib, Atorvastatin, Ezetimibe - Hyperlipidemia | Phase 3 | Terminated | Eli Lilly and Company | 366 | 2014-10-01 | 2019-10-08 |
| A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder. torcetrapib/atorvastatin, ezetimibe/simvastatin - Hyperlipidemia, Dyslipidemia | Phase 3 | Terminated | Pfizer | 1784 | 2006-01-01 | 2007-12-10 |
| A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031). torcetrapib/atorvastatin, simvastatin - Hyperlipidemia, Dyslipidemia | Phase 3 | Terminated | Pfizer | 640 | 2006-01-01 | 2012-02-17 |
| Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy Extended release niacin, Placebo - Diabetes Mellitus, Type 2, Kidney Failure, Chronic | Phase 3 | Terminated | University of Miami | 9 | 2005-04-01 | 2016-06-22 |
| A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia topiramate - Obesity, Hyperlipidemia | Phase 3 | Terminated | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 179 | 2001-05-01 | 2011-06-08 |
Hyperlipidemias (5) · Dyslipidemias (3) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Hypercholesterolemia (1) · Hypertriglyceridemia (1) · Kidney Failure, Chronic (1) · Obesity (1)
Lipid Metabolism Disorders (5) · Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5) · Dyslipidemias (2) · Endocrine System Diseases (2) · Glucose Metabolism Disorders (2) · Pathological Conditions, Signs and Symptoms (2) · Body Weight (1) · Chronic Disease (1) · Diabetes Mellitus (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1)
Atorvastatin (3) · torcetrapib (2) · Ezetimibe (1) · Ezetimibe, Simvastatin Drug Combination (1) · Niacin (1) · Simvastatin (1) · Topiramate (1) · evacetrapib (1)
Pfizer (2) · Eli Lilly and Company (1) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1) · University of Miami (1)
United States (4) · Puerto Rico (1)